Free tool
Oncology stocks
We cover 7 companies grouped under the Oncology theme. The median market value in the group is $20.71B. Across the group, the median move over the past trading day is −0.92%. Price change over the past year runs from −3.2% to +209.3% across the middle 80 percent of the group, with a median of +52.6%.
Other lists in this group
SaaSAI applicationsCybersecuritySemiconductor designSemiconductor equipmentFintech softwarePayment processingEcommerce marketplacesStreaming mediaGaming softwareOncologyRare diseaseMedical devicesCell therapyDiagnosticsRegional banksAsset managementGold miningCryptocurrency and digital assetsSpecialty chemicalsAll stocks
Table
7 of 319 companies match these filters.Clear filters
| Ticker | Company | Market cap (USD) | Size | 1Y return | Next report |
|---|---|---|---|---|---|
| 6MK.DE | Merck & Co., Inc. | $370.26B | Mega cap | +90.43% | Oct 29, 2026 |
| AZN.L | AstraZeneca PLC | $256.20B | Mega cap | +3.37% | Oct 30, 2026 |
| 0J9P.L | Incyte Corporation | $21.10B | Large cap | +52.56% | Oct 27, 2026 |
| GE9.DE | Genmab A/S | $20.71B | Large cap | −12.96% | Nov 5, 2026 |
| 0IJO.L | Exelixis, Inc. | $14.05B | Large cap | +47.40% | Oct 27, 2026 |
| 0I3Q.L | Corcept Therapeutics Incorporated | $4.54B | Mid cap | +70.11% | Nov 4, 2026 |
| NANO.PA | Nanobiotix S.A. | $2.25B | Mid cap | +387.64% | Sep 29, 2026 |
Covers ~22,000 companies across the US, Europe and Asia-Pacific (ex mainland China, Hong Kong and India), refreshed nightly. Every listed stock opens as a full analysis for $9.90.